Authors:
GILABERT J
ESTELLES A
GRANCHA S
ESPANA F
AZNAR J
Citation: J. Gilabert et al., FIBRINOLYTIC SYSTEM AND REPRODUCTIVE PROCESS WITH SPECIAL REFERENCE TO FIBRINOLYTIC FAILURE IN PREECLAMPSIA, Human reproduction, 10, 1995, pp. 121-131
Citation: A. Vaya et al., CEREBRAL VENOUS SINUS THROMBOSIS ASSOCIATED WITH REFRACTORY-ANEMIA WITH EXCESS OF BLASTS, Nouvelle revue francaise d'hematologie, 37(3), 1995, pp. 201-203
Authors:
GILABERT J
ESTELLES A
CANO A
ESPANA F
BARRACHINA R
GRANCHA S
AZNAR J
TORTAJADA M
Citation: J. Gilabert et al., THE EFFECT OF ESTROGEN REPLACEMENT THERAPY WITH OR WITHOUT PROGESTOGEN ON THE FIBRINOLYTIC SYSTEM AND COAGULATION INHIBITORS IN POSTMENOPAUSAL STATUS, American journal of obstetrics and gynecology, 173(6), 1995, pp. 1849-1854
Authors:
RODILLA F
MAGRANER J
AZNAR J
OROVITG F
ALCACER F
COLOMINA J
FERRIOLS F
Citation: F. Rodilla et al., AMPHOTERICIN-B FOR VISCERAL LEISHMANIASIS RESISTANT TO PENTAVALENT ANTIMONIAL DRUGS IN AIDS, The Annals of pharmacotherapy, 28(11), 1994, pp. 1305-1305
Citation: Ja. Raga et al., HADWENIUS PONTOPORIAE SP-N (DIGENEA, CAMPULIDAE) FROM THE INTESTINE OF FRANCISCANA (CETACEA, PONTOPORIIDAE) IN ARGENTINEAN WATERS, Journal of the Helminthological Society of Washington, 61(1), 1994, pp. 45-49
Authors:
MARTINEZMARCOS F
CISNEROS J
GENTIL M
ALGARRA G
PEREIRA P
AZNAR J
PACHON J
Citation: F. Martinezmarcos et al., PROSPECTIVE-STUDY OF RENAL-TRANSPLANT INFECTIONS IN 50 CONSECUTIVE PATIENTS, European journal of clinical microbiology & infectious diseases, 13(12), 1994, pp. 1023-1028
Authors:
GILABERT J
ESTELLES A
AYUSO MJ
ESPANA F
CHIRIVELLA M
GRANCHA S
MICO JM
AZNAR J
Citation: J. Gilabert et al., EVALUATION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN PLASMA AND AMNIOTIC-FLUID IN PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION, Gynecologic and obstetric investigation, 38(3), 1994, pp. 157-162
Citation: J. Aznar et A. Estelles, ROLE OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN THE PATHOGENESIS OFCORONARY-ARTERY DISEASES, Haemostasis, 24(4), 1994, pp. 243-251
Authors:
ESTELLES A
GILABERT J
ESPANA F
VILA J
MARTINEZ M
HENDL S
AZNAR J
Citation: A. Estelles et al., ALTERATIONS IN FIBRINOLYTIC AND PROTEIN-C PATHWAYS IN GYNECOLOGICAL SURGERY - LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS, Haemostasis, 24(4), 1994, pp. 252-260
Authors:
VALLES J
SANTOS MT
AZNAR J
MARCUS AJ
BROEKMAN MJ
SAFIER LB
Citation: J. Valles et al., A LOADING DOSE OF 500-MG ASPIRIN EVERY 2 WEEKS, SUPPLEMENTED WITH 50-MG DAILY, EXERTS BETTER CONTROL OF PLATELET REACTIVITY THAN CONTINUOUSLOW-DOSE ASPIRIN, Blood, 84(10), 1994, pp. 10000086-10000086
Authors:
ESTELLES A
GILABERT J
KEETON M
EGUCHI Y
AZNAR J
GRANCHA S
ESPANA F
LOSKUTOFF DJ
SCHLEEF RR
Citation: A. Estelles et al., ALTERED EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PLACENTAS FROM PREGNANT-WOMEN WITH PREECLAMPSIA AND OR INTRAUTERINE PETAL GROWTH-RETARDATION/, Blood, 84(1), 1994, pp. 143-150
Authors:
REGANON E
VILA V
AZNAR J
LACUEVA V
MARTINEZ V
RUANO M
Citation: E. Reganon et al., STUDIES ON THE FUNCTIONALITY OF NEWLY SYNTHESIZED FIBRINOGEN AFTER TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH STREPTOKINASE, INCREASE INTHE RATE OF FIBRINOPEPTIDE RELEASE, Thrombosis and haemostasis, 70(6), 1993, pp. 978-983
Authors:
VALLES J
SANTOS MT
AZNAR J
MARCUS AJ
SAFIER LB
BROEKMAN MJ
Citation: J. Valles et al., EFFECTS OF DIFFERENT DOSES OF ASPIRIN ON EX-VIVO PLATELET RECRUITMENT- MODULATORY ROLE OF ERYTHROCYTES, Thrombosis and haemostasis, 69(6), 1993, pp. 633-633
Citation: V. Vila et al., UNSTIMULATED AND THROMBIN-STIMULATED PLATELETS ADHESION TO IMMOBILIZED FIBRINOGEN AND FIBRIN, Thrombosis and haemostasis, 69(6), 1993, pp. 693-693
Citation: V. Martinezsales et al., DISTRIBUTION OF FIBRINOGEN IN UNSTIMULATED AND THROMBIN-STIMULATED PLATELETS, Thrombosis and haemostasis, 69(6), 1993, pp. 694-694
Authors:
ESPANA F
SANCHEZCUENCA J
VERA CD
ESTELLES A
GILABERT J
AZNAR J
Citation: F. Espana et al., A QUANTITATIVE ELISA FOR THE MEASUREMENT OF COMPLEXES OF PROSTATE-SPECIFIC ANTIGEN WITH PROTEIN-C INHIBITOR USING A PURIFIED STANDARD, Thrombosis and haemostasis, 69(6), 1993, pp. 868-868
Authors:
ESPANA F
VICENTE V
ESTELLES A
VAZQUEZ L
HENDL SM
SANCHEZCUENCA J
AZNAR J
Citation: F. Espana et al., ACTIVATION OF PROTEIN-C AND COMPLEX-FORMATION BETWEEN PROTEIN-C INHIBITOR AND TISSUE-PLASMINOGEN ACTIVATOR DURING THROMBOLYTIC THERAPY, Thrombosis and haemostasis, 69(6), 1993, pp. 896-896
Authors:
ESPANA F
ESTELLES A
HENDL SM
GILABERT J
AZNAR J
GRIFFIN JH
Citation: F. Espana et al., EVIDENCE FOR THE PHYSIOLOGICAL REGULATION OF UROKINASE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS BY THE SERPIN, PROTEIN-C INHIBITOR, IN SEMEN,URINE AND BLOOD, Thrombosis and haemostasis, 69(6), 1993, pp. 896-896
Authors:
FERNANDEZ JA
ESPANA F
GILABERT J
ESTELLES A
AZNAR J
Citation: Ja. Fernandez et al., DECREASED LEVELS OF PROTEIN-C INHIBITOR DURING PREGNANCY AND PUERPERIUM, Thrombosis and haemostasis, 69(6), 1993, pp. 898-898
Authors:
REGANON E
VILA V
AZNAR J
LACUEVA V
MARTINEZSALES V
RUANO M
Citation: E. Reganon et al., INCREASED RATE OF FIBRINOPEPTIDE RELEASE OF FIBRINOGEN IN ACUTE MYOCARDIAL-INFARCTION AFTER THROMBOLYTIC THERAPY, Thrombosis and haemostasis, 69(6), 1993, pp. 1351-1351
Authors:
VALLES J
AZNAR J
SANTOS T
VILLA P
FERNANDEZ A
Citation: J. Valles et al., PLATELET-FUNCTION IN PATIENTS WITH CHRONIC CORONARY HEART-DISEASE ON LONG-TERM ANTICOAGULANT-THERAPY - EFFECT OF ANTICOAGULANT STOPPING, Haemostasis, 23(4), 1993, pp. 212-218